These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2661911)

  • 1. Is there a hierarchy of methods in clinical research?
    Vandenbroucke JP
    Klin Wochenschr; 1989 May; 67(10):515-7. PubMed ID: 2661911
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current significance of retrospective studies].
    Feifel G; Menger MD
    Chirurg; 1989 Apr; 60(4):214-8. PubMed ID: 2656128
    [No Abstract]   [Full Text] [Related]  

  • 3. Postmarketing studies of drug efficacy: when must they be randomized?
    Strom BL; Miettinen OS; Melmon KL
    Clin Pharmacol Ther; 1983 Jul; 34(1):1-7. PubMed ID: 6861430
    [No Abstract]   [Full Text] [Related]  

  • 4. [The concept, structure and practice of prospective clinical studies].
    Neugebauer E; Rothmund M; Lorenz W
    Chirurg; 1989 Apr; 60(4):203-13. PubMed ID: 2656127
    [No Abstract]   [Full Text] [Related]  

  • 5. [Necessity and field of application of retrospective analyses in a time of prospective controlled studies (author's transl)].
    Bertram E; Farthmann EH
    Langenbecks Arch Chir; 1981; 355():393-7. PubMed ID: 7339375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinimetrics in nephrology.
    Parfrey PS; Gault MH
    Nephron; 1986; 42(1):1-5. PubMed ID: 3941747
    [No Abstract]   [Full Text] [Related]  

  • 7. When and how to stop a clinical trial: invited remarks.
    Chalmers TC
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 2):649-50. PubMed ID: 373948
    [No Abstract]   [Full Text] [Related]  

  • 8. Postmarketing studies of drug efficacy.
    Strom BL; Melmon KL; Miettinen OS
    Arch Intern Med; 1985 Oct; 145(10):1791-4. PubMed ID: 3899034
    [No Abstract]   [Full Text] [Related]  

  • 9. When and how to stop a clinical trial: invited remarks.
    Stamler J
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 2):651-4. PubMed ID: 373949
    [No Abstract]   [Full Text] [Related]  

  • 10. Communications: Should mechanisms be established for sharing among clinical trial investigators experiences in handling problems in design, execution, and analysis? Problems of omission in communications.
    Mosteller F
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 2):761-4. PubMed ID: 373970
    [No Abstract]   [Full Text] [Related]  

  • 11. Implementing randomization.
    Roos LL; Roos NP; McKinley B
    Policy Anal; 1977; 3(4):547-59. PubMed ID: 10236552
    [No Abstract]   [Full Text] [Related]  

  • 12. The evaluation of clinical trials.
    Jackson RR
    Postgrad Med J; 1985 Feb; 61(712):133-9. PubMed ID: 3983040
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of observational studies in the evaluation of therapy.
    Feinstein A
    Stat Med; 1984; 3(4):341-5. PubMed ID: 6528134
    [No Abstract]   [Full Text] [Related]  

  • 14. Rules of evidence and clinical recommendations on the use of antithrombotic agents.
    Sackett DL
    Chest; 1989 Feb; 95(2 Suppl):2S-4S. PubMed ID: 2914516
    [No Abstract]   [Full Text] [Related]  

  • 15. Randomised controlled trials and retrospective controls.
    Cranberg L
    Br Med J; 1980 Mar; 280(6217):866. PubMed ID: 7370710
    [No Abstract]   [Full Text] [Related]  

  • 16. The design of cancer prevention trials.
    Byar DP
    Recent Results Cancer Res; 1988; 111():34-48. PubMed ID: 3175310
    [No Abstract]   [Full Text] [Related]  

  • 17. Is surgery worthwhile?
    Salzman EW
    Arch Surg; 1985 Jul; 120(7):771-6. PubMed ID: 4015363
    [No Abstract]   [Full Text] [Related]  

  • 18. When and how to stop a clinical trial: introduction.
    Meinert CL
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 2):632. PubMed ID: 373944
    [No Abstract]   [Full Text] [Related]  

  • 19. The odds ratio: a useful tool in neurosciences.
    Sandercock P
    J Neurol Neurosurg Psychiatry; 1989 Jul; 52(7):817-20. PubMed ID: 2769272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When and how to stop a clinical trial: invited remarks.
    Hamilton MT
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 2):647-8. PubMed ID: 373947
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.